Nu Skin Enterprises, Inc. (NUS) Guidance & Earnings Results

On 2026-08-10 Nu Skin Enterprises, Inc. lowered guidance: "FY26 revenue $1.28-1.35B (prior not stated but implies cut from earlier guidance); FY26 adjusted EPS $0.70-0.90; Q3 revenue $310-340M; Q3 adjusted EPS…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

NUSNu Skin Enterprises, Inc.Follow NUS — free

Household & Personal Products · Consumer Defensive

—

Price chart with a free account

Market cap: 233.2M
P/E TTM: —
Dividend yield: 5.0%
52-week: —
Next earnings: 4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
10 Aug 26	Lowered	FY26 revenue $1.28-1.35B (prior not stated but implies cut from earlier guidance); FY26 adjusted EPS $0.70-0.90; Q3 revenue $310-340M; Q3 adjusted EPS $0.10-0.20 · full year
7 May 26	Reaffirmed	Q2 2026 Revenue $330-360M; Q2 2026 EPS $0.15-0.25; FY2026 Revenue $1.35-1.50B; FY2026 EPS $0.70-1.10 ($0.80-1.20 ex-items) · full year
12 Feb 26	Mixed	Q1 2026 revenue $320-340M (-12% to -7% YoY); 2026 revenue $1.35-1.50B (-9% to +1%); Q1 EPS $0.10-0.20; 2026 EPS $0.80-1.20 · full year
6 Nov 25	Reaffirmed	FY2025 revenue $1.48-1.51B (narrowed); EPS $3.15-3.25 ($1.25-1.35 adjusted); Q4 revenue $365-400M, EPS $0.25-0.35 · full year
7 Aug 25	Raised	FY2025 revenue narrowed to $1.48-1.55B from $1.48-1.55B (narrowed); FY2025 EPS raised to $3.05-3.25 from $2.90-3.10 (implied); Q3 2025 revenue $360-390M; Q3 2025 EPS $0.25-0.35. · full year

Nu Skin Enterprises, Inc. — questions

What guidance did Nu Skin Enterprises, Inc. give?: On 2026-08-10: "FY26 revenue $1.28-1.35B (prior not stated but implies cut from earlier guidance); FY26 adjusted EPS $0.70-0.90; Q3 revenue $310-340M; Q3 adjusted EPS $0.10-0.20"
When does Nu Skin Enterprises, Inc. report earnings?: Nu Skin Enterprises, Inc.'s next earnings report is expected on 2026-11-04.

Every figure on this page comes from Nu Skin Enterprises, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.